Navellier & Associates’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

Navellier & Associates’s Portfolio SCLN Stock Details SCLN Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell
2017 Q2	$286K	Sell
2017 Q1	$298K	Buy
2016 Q4	$301K	Buy
2016 Q3	$147K	Buy